CPHI China 2025: Meet Hebei Xingang Pharmaceutical at Booth W7A15

Event Details:

• Date: June 24-26, 2025
• Location: Shanghai New International Expo Center (Pudong)
• Booth: W7A15

Hebei Xingang Pharmaceutical Co Ltd, a globally recognized leader in rifamycin series products and anti-tuberculosis (TB) APIs, will showcase its cutting-edge pharmaceutical solutions at the 23rd China International Pharmaceutical Ingredients Exhibition (CPHI China 2025). As a trusted partner to formulation manufacturers worldwide, the company invites industry professionals to explore its high-quality intermediates, advanced production capabilities, and commitment to global health innovation.

Why Visit Hebei Xingang Pharmaceutical at Booth W7A15?

1. Premium Rifamycin APIs & Intermediates

Specializing in rifampicin, rifapentine, rifaximin, and rifabutin, Hebei Xingang Pharmaceutical supplies critical ingredients for:

• Tuberculosis (TB) treatment
• Broad-spectrum antibiotic formulations
• Gastrointestinal health products

Their product portfolio meets stringent pharmacopeia standards (BP/EP/USP) and serves clients in 50+ countries, including India, Germany, Brazil, and Africa.

2. State-of-the-Art Manufacturing & Compliance

• WHO GMP Certified: Validated by global health authorities, ensuring compliance with international quality benchmarks.
• Advanced Facilities:
  • Computer-controlled fermentation and extraction workshops.
  • Separate production lines for API synthesis, minimizing cross-contamination risks.
  • Oil-free air compressors and closed vacuum systems for ultra-pure output.

3. Decades of Expertise & Innovation

Since 1996, the company has pioneered rifamycin biotechnology fermentation and built a reputation as a high-tech enterprise with:

• Provincial-level R&D projects and patented fermentation optimizations.
• In-house microbial labs with stainless steel fermentation tanks and modern testing instruments.
  
  
  

Global Reach, Local Expertise

Hebei Xingang Pharmaceutical’s products are trusted by leading pharmaceutical companies across:

• Asia: India, Indonesia, Vietnam
• Europe: Germany, Russia
• Americas: Chile, Brazil
• Africa: Key markets in TB-endemic regions

Their dedicated international sales team provides rapid response to regulatory audits, quality certifications, and supply chain inquiries.

Visit Booth W7A15 for:

• Live demos of rifamycin S-Na salt and 3-F intermediates.
• Discussions on custom synthesis and scalable API production.
• Partnerships with a 20+ year industry veteran in anti-infective solutions.